Organogenesis Holdings Inc. provided earnings guidance for the year ending December 31, 2021. For the twelve months ending December 31, 2021, the Company now expects net revenue of between $458 million and $470 million, representing an increase of approximately 35% to 39% year-over-year, as compared to net revenue of $338.3 million for the twelve months ended December 31, 2020 and GAAP net income positive for the twelve months ended December 31, 2021.